Metastatic NSCLC - non-small cell lung cancer
Clinical trials for Metastatic NSCLC - non-small cell lung cancer explained in plain language.
Never miss a new study
Get alerted when new Metastatic NSCLC - non-small cell lung cancer trials appear
Sign up with your email to follow new studies for Metastatic NSCLC - non-small cell lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Zapping resistant spots: radiation may buy more time for lung cancer patients on targeted drugs
Disease control Not yet recruitingThis study tests whether precisely targeted radiation (SBRT) can stop or slow the growth of a few resistant spots in metastatic lung cancer patients who are already on targeted therapy (TKI). About 60 adults with EGFR or ALK mutations will receive radiation to those spots, and do…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug XTX501 takes aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a new drug called XTX501 in people with metastatic non-small cell lung cancer (NSCLC) or other advanced solid tumors. The goal is to see if the drug is safe and can shrink tumors. Participants receive XTX501 alone, and researchers monitor side effects and how wel…
Matched conditions: METASTATIC NSCLC - NON-SMALL CELL LUNG CANCER
Phase 1/2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC